CME in Minutes: Education in Primary Care

Please visit answersincme.com/PXD860 to participate, download slides and supporting materials, complete the post test, and get a certificate. Presented by Ticiana Leal, MD. In this activity, an expert in thoracic oncology discusses the latest data for immunotherapy-based combination regimens in the treatment of non–small-cell lung cancer. Upon completion of this activity, participants should be better able to: Discuss the latest efficacy and safety data for immunotherapy (ICI)-based regimens in the treatment of non–small-cell lung cancer (NSCLC), including ICI + tyrosine kinase inhibitor (TKI) combinations; Assess how emerging data on immunotherapy-based regimens may influence the evolving treatment landscape for patients with NSCLC; and Incorporate the latest evidence on approved and emerging ICI-based regimens into practical NSCLC management across disease settings.

Please visit answersincme.com/860/04572-replay2 to participate, download slides and supporting materials, complete the post test, and get a certificate. Presented by Cedric James Franklin Rutland, MD, FCCP; Stephanie Christenson, MD, MAS; and Surya P. Bhatt, MD, MSPH. In this activity, experts in chronic obstructive pulmonary disease (COPD) discuss the role of eosinophil testing, biologic therapies, and strategies for individualized, guideline-based treatment. Upon completion of this activity, participants should be better able to: Recognize the role of eosinophils and eosinophilic testing in COPD; Select biologic therapies for appropriate patients with eosinophilic COPD, based on the latest evidence and guidance; and Collaborate with an interdisciplinary team to integrate the latest guideline recommendations into individualized treatment plans tailored to patient and disease characteristics. This activity is intended for US healthcare professionals only.

Please visit answersincme.com/860/04572-replay1 to participate, download slides and supporting materials, complete the post test, and get a certificate. Presented by Cedric James Franklin Rutland, MD, FCCP; Stephanie Christenson, MD, MAS; and David Mannino, MD, FCCP, FERS. In this activity, experts in chronic obstructive pulmonary disease (COPD) discuss the role of eosinophil testing, biologic therapies, and strategies for individualized, guideline-based treatment. Upon completion of this activity, participants should be better able to: Recognize the role of eosinophils and eosinophilic testing in COPD; Select biologic therapies for appropriate patients with eosinophilic COPD, based on the latest evidence and guidance; and Collaborate with an interdisciplinary team to integrate the latest guideline recommendations into individualized treatment plans tailored to patient and disease characteristics. This activity is intended for US healthcare professionals only.

Please visit answersincme.com/ZSN860 to participate, download slides and supporting materials, complete the post test, and get a certificate. Presented by Wanda Phipatanakul, MD, MS. In this activity, an expert in pediatric asthma discusses how to identify type 2 inflammation and tailor biologic therapy for pediatric patients with asthma. Upon completion of this activity, participants should be better able to: Identify the impact of type 2 inflammation on lung function in pediatric patients with asthma; Recognize best practices for incorporating biologics into the treatment of type 2 inflammatory pediatric asthma; and Outline the role of multidisciplinary teams in optimizing outcomes for pediatric patients with type 2 inflammatory asthma. This activity is intended for US healthcare professionals only.

Please visit answersincme.com/JJK860 to participate, download slides and supporting materials, complete the post test, and get a certificate. Presented by Rajsekar (Raj) Rajaraman, MD, MS. In this activity, an expert in pediatric neurology discusses the diagnosis and management of CDKL5 deficiency disorder. Upon completion of this activity, participants should be better able to: Describe key clinical characteristics that contribute to the burden of CDKL5 deficiency disorder (CDD); Evaluate the role of timely diagnosis in influencing care decisions for individuals with CDD; and Outline therapeutic approaches for managing seizures associated with CDD.